HIS news
SWOG S0221 Phase III Trial Compares AC Dosing Schedules Followed by Paclitaxel in High-Risk Resected Breast Cancer
The randomized phase III trial is evaluating two AC dosing schedules followed by paclitaxel in node-positive or high-risk node-negative breast cancer.
Read news
